Overview

Iloprost-Study: Comparison of Nitric Oxide to Iloprost (Ventavis) for Treatment of Pulmonary Hypertension in Children After Cardiopulmonary Bypass Surgery

Status:
Completed

Trial end date:
2008-10-01

Target enrollment:

Participant gender:

Summary

Inhaled nitrous oxide (iNO) will be compared to aerosolized iloprost (ILO) in pediatric patients after cardiac surgery with pulmonary hypertension. The hypothesis is that iloprost is more effective in preventing pulmonary hypertensive crises.

Phase:

N/A

Details

Lead Sponsor:

Heidelberg University

Treatments:

Iloprost
Nitric Oxide